Ubiquitin and SUMO conjugation as biomarkers of acute myeloid leukemias response to chemotherapies

Pierre Gâtel; Frédérique Brockly; Christelle Reynes; Manuela Pastore; Yosr Hicheri; Guillaume Cartron; Marc Piechaczyk; Guillaume Bossis

doi:10.26508/lsa.201900577

Research Article

Open Access

Ubiquitin and SUMO conjugation as biomarkers of acute myeloid leukemias response to chemotherapies

Pierre Gâtel, Frédérique Brockly, Christelle Reynes, Manuela Pastore, Yosr Hicheri, Guillaume Cartron, View ORCID ProfileMarc Piechaczyk, View ORCID ProfileGuillaume Bossis Correspondence email

Pierre Gâtel

1Institut de Génétique Moléculaire de Montpellier (IGMM), University of Montpellier, CNRS, Montpellier, France

2Equipe Labellisée Ligue Contre le Cancer, Paris, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Frédérique Brockly

1Institut de Génétique Moléculaire de Montpellier (IGMM), University of Montpellier, CNRS, Montpellier, France

2Equipe Labellisée Ligue Contre le Cancer, Paris, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christelle Reynes

3Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, Montpellier, France

4BioCampus Montpellier (BCM), University of Montpellier, CNRS, INSERM, Montpellier, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Manuela Pastore

4BioCampus Montpellier (BCM), University of Montpellier, CNRS, INSERM, Montpellier, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yosr Hicheri

5Département d’Hématologie Clinique, CHU de Montpellier, Montpellier, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Guillaume Cartron

1Institut de Génétique Moléculaire de Montpellier (IGMM), University of Montpellier, CNRS, Montpellier, France

5Département d’Hématologie Clinique, CHU de Montpellier, Montpellier, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marc Piechaczyk

1Institut de Génétique Moléculaire de Montpellier (IGMM), University of Montpellier, CNRS, Montpellier, France

2Equipe Labellisée Ligue Contre le Cancer, Paris, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Marc Piechaczyk

Guillaume Bossis

1Institut de Génétique Moléculaire de Montpellier (IGMM), University of Montpellier, CNRS, Montpellier, France

2Equipe Labellisée Ligue Contre le Cancer, Paris, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Guillaume Bossis
For correspondence: guillaume.bossis@igmm.cnrs.fr

Published 17 April 2020. DOI: 10.26508/lsa.201900577

Article
Figures & Data
Info
Metrics
Reviewer Comments
PDF

You are using an old browser, click here to download PDF

PDF Container

PreviousNext

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Ubiquitin and SUMO conjugation as biomarkers of acute myeloid leukemias response to chemotherapies

Message Subject (Your Name) has sent you a message from Life Science Alliance

Message Body (Your Name) thought you would like to see the Life Science Alliance web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Ubiquitin-like biomarkers of AML resistance to treatments